loading page

A liver metastasis 7 years after resection of a low-risk duodenal gastrointestinal stromal tumor
  • +9
  • Masashi Inoue,
  • Masayuki Shishida,
  • Atsuhiro Watanabe,
  • Ryujiro Kajikawa,
  • Ryotaro Kajiwara,
  • Hiroyuki Sawada,
  • Ichiro Omori,
  • Kazuaki Miyamoto,
  • Masahiro Ikeda,
  • Kazuhiro Toyota,
  • Seiji Sadamoto,
  • Tadateru Takahashi
Masashi Inoue
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Masayuki Shishida
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Atsuhiro Watanabe
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Ryujiro Kajikawa
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Ryotaro Kajiwara
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Hiroyuki Sawada
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Ichiro Omori
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Kazuaki Miyamoto
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Masahiro Ikeda
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Kazuhiro Toyota
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Seiji Sadamoto
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile
Tadateru Takahashi
National Hospital Organization Higashi Hiroshima Medical Center
Author Profile

Abstract

Duodenal gastrointestinal stromal tumors (dGISTs) are rare, and a lack of consensus exists regarding their therapeutic management particularly for recurrent disease. We present even low-risk dGIST may metastasize and require long-term observation, and a long-term prognosis may be achieved by combining resection and imatinib therapy for liver metastases recurrence.